Epidemiology of Gender Differences in Diabetes and Obesity

  • Franck Mauvais-Jarvis
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1043)


Some aspects of glucose homeostasis and energy balance are regulated differently in males and females. This review discusses the most fundamental gender differences in diabetes and obesity, including the prevalence of impaired fasting glucose and impaired glucose tolerance, the prevalence and incidence of type 2 and type 1 diabetes, as well as the prevalence of metabolic syndrome and obesity. These gender-specific differences in glucose homeostasis and energy balance represent a source of factors that should be studied to develop gender-based therapeutic avenues for diabetes.



This work was supported by grants from the National Institutes of Health (DK074970, DK107444), the American Diabetes Association (7-13-BS-101), and a VA Merit Review Award (BX003725).


  1. Aguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015). Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA, 313, 1973–1974.CrossRefPubMedGoogle Scholar
  2. Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003). Prevalence of the metabolic syndrome among Omani adults. Diabetes Care, 26, 1781–1785.CrossRefPubMedGoogle Scholar
  3. Basu, R., Dalla Man, C., Campioni, M., Basu, A., Klee, G., Toffolo, G., Cobelli, C., & Rizza, R. A. (2006). Effects of age and sex on postprandial glucose metabolism: Differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes, 55, 2001–2014.CrossRefPubMedGoogle Scholar
  4. Blohme, G., Nystrom, L., Arnqvist, H. J., Lithner, F., Littorin, B., Olsson, P. O., Schersten, B., Wibell, L., & Ostman, J. (1992). Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: Results from a 5-year prospective nationwide study of the 15–34-year age group in Sweden. Diabetologia, 35, 56–62.CrossRefPubMedGoogle Scholar
  5. Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004). Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care, 27, 2444–2449.CrossRefPubMedGoogle Scholar
  6. Frias, J. P., Macaraeg, G. B., Ofrecio, J., Yu, J. G., Olefsky, J. M., & Kruszynska, Y. T. (2001). Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes, 50, 1344–1350.CrossRefPubMedGoogle Scholar
  7. Gale, E. A., & Gillespie, K. M. (2001). Diabetes and gender. Diabetologia, 44, 3–15.CrossRefPubMedGoogle Scholar
  8. Glumer, C., Jorgensen, T., & Borch-Johnsen, K. (2003). Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care, 26, 2335–2340.CrossRefPubMedGoogle Scholar
  9. Gourdy, P., Bourgeois, E. A., Levescot, A., Pham, L., Riant, E., Ahui, M. L., Damotte, D., Gombert, J. M., Bayard, F., Ohlsson, C., Arnal, J. F., & Herbelin, A. (2016). Estrogen therapy delays autoimmune diabetes and promotes the protective efficiency of natural killer T-cell activation in female nonobese diabetic mice. Endocrinology, 157, 258–267.CrossRefPubMedGoogle Scholar
  10. Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005). Prevalence of the metabolic syndrome and overweight among adults in China. Lancet, 365, 1398–1405.CrossRefPubMedGoogle Scholar
  11. Gupta, R., Deedwania, P. C., Gupta, A., Rastogi, S., Panwar, R. B., & Kothari, K. (2004). Prevalence of metabolic syndrome in an Indian urban population. International Journal of Cardiology, 97, 257–261.CrossRefPubMedGoogle Scholar
  12. Kelly, T., Yang, W., Chen, C. S., Reynolds, K., & He, J. (2008). Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity, 32, 1431–1437.CrossRefPubMedGoogle Scholar
  13. Louet, J. F., Smith, S. B., Gautier, J. F., Molokhia, M., Virally, M. L., Kevorkian, J. P., Guillausseau, P. J., Vexiau, P., Charpentier, G., German, M. S., Vaisse, C., Urbanek, M., & Mauvais-Jarvis, F. (2008). Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes. Diabetes, Obesity & Metabolism, 10, 912–920.CrossRefGoogle Scholar
  14. Martinez, D., Castro, A., Merino, P. M., Lopez, P., Lardone, M. C., Iniguez, G., Cassorla, F., & Codner, E. (2016). Oestrogen activity of the serum in adolescents with Type 1 diabetes. Diabetic Medicine, 33, 1366–1373.CrossRefPubMedGoogle Scholar
  15. Mauvais-Jarvis, F. (2016). Role of sex steroids in beta cell function, growth, and survival. Trends in Endocrinology and Metabolism, 27, 844–855.CrossRefPubMedCentralPubMedGoogle Scholar
  16. Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017). Menopausal hormone therapy and type 2 diabetes prevention: Evidence, mechanisms and clinical implications. Endocrine Reviews, 38, 173–188.CrossRefPubMedGoogle Scholar
  17. Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J. P., Kevorkian, J. P., Vaisse, C., Charpentier, G., Guillausseau, P. J., Vexiau, P., & Gautier, J. F. (2004). Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: Clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes, 53, 645–653.CrossRefPubMedGoogle Scholar
  18. Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015). Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA, 314, 1021–1029.CrossRefPubMedGoogle Scholar
  19. Mozumdar, A., & Liguori, G. (2011). Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care, 34, 216–219.CrossRefPubMedGoogle Scholar
  20. Nuutila, P., Knuuti, M. J., Maki, M., Laine, H., Ruotsalainen, U., Teras, M., Haaparanta, M., Solin, O., & Yki-Jarvinen, H. (1995). Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes, 44, 31–36.CrossRefPubMedGoogle Scholar
  21. Nystrom, L., Dahlquist, G., Ostman, J., Wall, S., Arnqvist, H., Blohme, G., Lithner, F., Littorin, B., Schersten, B., & Wibell, L. (1992). Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: Indications of climatological determinants for age at onset. International Journal of Epidemiology, 21, 352–358.CrossRefPubMedGoogle Scholar
  22. Samuelsson, U., Lindblad, B., Carlsson, A., Forsander, G., Ivarsson, S., Kockum, I., Lernmark, A., Marcus, C., & Ludvigsson, J. (2013). Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season. Diabetes/Metabolism Research and Reviews, 29, 85–89.CrossRefPubMedCentralPubMedGoogle Scholar
  23. Sicree, R. A., Zimmet, P. Z., Dunstan, D. W., Cameron, A. J., Welborn, T. A., & Shaw, J. E. (2008). Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabetic Medicine, 25, 296–302.CrossRefPubMedGoogle Scholar
  24. Tiano, J. P., & Mauvais-Jarvis, F. (2012). Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nature Reviews Endocrinology, 8, 342–351.CrossRefPubMedGoogle Scholar
  25. Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006). Narrative review: Ketosis-prone type 2 diabetes mellitus. Annals of Internal Medicine, 144, 350–357.CrossRefPubMedGoogle Scholar
  26. Van Genugten, R. E., Utzschneider, K. M., Tong, J., Gerchman, F., Zraika, S., Udayasankar, J., Boyko, E. J., Fujimoto, W. Y., & Kahn, S. E. (2006). Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes, 55, 3529–3535.CrossRefPubMedGoogle Scholar
  27. Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047–1053.CrossRefPubMedGoogle Scholar
  28. Williams, J. W., Zimmet, P. Z., Shaw, J. E., De Courten, M. P., Cameron, A. J., Chitson, P., Tuomilehto, J., & Alberti, K. G. (2003). Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabetic Medicine, 20, 915–920.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Medicine, Section of Endocrinology and MetabolismTulane University Health Sciences Center, School of MedicineNew OrleansUSA

Personalised recommendations